Synopsis
Synopsis
0
JDMF
0
EU WC
0
VMF
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Acetate, Megestrol
2. Apo Megestrol
3. Apo-megestrol
4. Apomegestrol
5. Borea
6. Lin Megestrol
7. Lin-megestrol
8. Linmegestrol
9. Maygace
10. Megace
11. Megefren
12. Megestat
13. Megostat
14. Mestrel
15. Nu Megestrol
16. Nu-megestrol
17. Numegestrol
1. 595-33-5
2. Megace
3. Megace Es
4. Niagestin
5. Megestryl Acetate
6. Megeron
7. Megestat
8. Ovaban
9. Ovarid
10. Maygace
11. Pallace
12. Bdh 1298
13. Magestin
14. Sc 10363
15. Nsc-71423
16. Volidan
17. Sc10363
18. 17alpha-hydroxy-6-methylpregna-4,6-diene-3,20-dione Acetate
19. Megesterol Acetate
20. 17alpha-acetoxy-6-dehydro-6-methylprogesterone
21. 6-dehydro-6-methyl-17alpha-acetoxyprogesterone
22. 6-methyl-6-dehydro-17alpha-acetoxyprogesterone
23. 17-hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate
24. 17-acetoxy-6-methylpregna-4,6-diene-3,20-dione
25. Sc-10363
26. 17-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione
27. Bdh-1298
28. 6-methyl-17alpha-hydroxy-delta(sup 6)-progesterone Acetate
29. Tj2m0fr8es
30. [(8r,9s,10r,13s,14s,17r)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1h-cyclopenta[a]phenanthren-17-yl] Acetate
31. Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-6-methyl-
32. 6-methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate
33. Megestrol 17.alpha.-acetate
34. Mls000028633
35. 17-hydroxy-6-methylpregna-4,6-diene-3,20-dione Acetate
36. Bdh1298
37. Smr000058691
38. Dsstox_cid_20683
39. Dsstox_rid_79539
40. Dsstox_gsid_40683
41. Megestil
42. 6-methyl-17alpha-acetoxypregna-4,6-diene-3,20-dione
43. Ovaban (veterinary)
44. 6-methyl-delta(sup 6)-dehydro-17alpha-acetoxyprogesterone
45. Megestrolacetate
46. 6-methyl-delta(sup 4,6)-pregnadien-17alpha-ol-3,20-dione Acetate
47. Megestrol Acetate [usan]
48. (8xi,9xi,10xi,13xi,14xi)-6-methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate
49. Ccris 372
50. Pregna-4,6-diene-3,20-dione, 17-hydroxy-6-methyl-, Acetate
51. Megestrol-17-acetate
52. Einecs 209-864-5
53. Unii-tj2m0fr8es
54. Megestin
55. Megestrol Acetole [progestins]
56. Megestrol Acetate [usan:usp]
57. Megestrol Acetole
58. Megestrol-acetate
59. 17-alpha-acetoxy-6-dehydro-6-methylprogesterone
60. 6-dehydro-6-methyl-17-alpha-acetoxyprogesterone
61. 6-methyl-6-dehydro-17-alpha-acetoxyprogesterone
62. Ncgc00016516-01
63. (8r,9s,10r,13s,14s,17r)-17-acetyl-6,10,13-trimethyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl Acetate
64. Cas-595-33-5
65. Megace (tn)
66. 17alpha-acetoxy-6-methylpregna-4,6-diene-3,20-dione
67. 6-methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione
68. 6-methyl-17-alpha-hydroxy-delta(sup 6)-progesterone Acetate
69. 6-methyl-6-dehydro-17.alpha.-acetylprogesterone
70. 6-methyl-delta(sup 6)-dehydro-17-alpha-acetoxyprogesterone
71. 6-methyl-delta4,6-pregnadien-17alpha-ol-3,20-dione Acetate
72. 17.alpha.-acetoxy-6-dehydro-6-methylprogesterone
73. 6-dehydro-6-methyl-17.alpha.-acetoxyprogesterone
74. 6-methyl-6-dehydro-17.alpha.-acetoxyprogesterone
75. Megestrol Acetate (usp)
76. Opera_id_1511
77. Prestwick0_000956
78. Prestwick1_000956
79. Prestwick2_000956
80. Prestwick3_000956
81. 6-methyl-delta(sup 4,6)-pregnadien-17-alpha-ol-3,20-dione Acetate
82. Schembl745
83. Bspbio_000952
84. Mls000759501
85. Mls001074091
86. Mls001424055
87. Par-100,2
88. Spbio_003101
89. Megestrol Acetate [mi]
90. Bpbio1_001048
91. Chebi:6723
92. Chembl1201139
93. Dtxsid9040683
94. Megestrol Acetate [vandf]
95. Megestrol Acetate [mart.]
96. Bcpp000168
97. Hms1570p14
98. Hms2051i20
99. Hms2090n04
100. Hms2097p14
101. Hms2235d16
102. Hms3714p14
103. Megestrol Acetate [usp-rs]
104. Megestrol Acetate [who-dd]
105. Megestrol Acetate [who-ip]
106. Nia
107. Nsc71423
108. Zinc4097467
109. Tox21_110469
110. Tox21_302360
111. Lmst02030118
112. Mfcd00056470
113. S1304
114. Akos015894927
115. Megestrol Acetate [green Book]
116. Tox21_110469_1
117. Bcp9000904
118. Ccg-100899
119. Cs-2065
120. Db00351
121. Megestrol Acetate [orange Book]
122. Nc00149
123. Megestrol Acetate [ep Monograph]
124. 17-acetoxy-6-methylpregna-4,20-dione
125. Megestrol Acetate [usp Monograph]
126. Ncgc00024196-03
127. Ncgc00024196-05
128. Ncgc00255456-01
129. Ac-24570
130. As-13384
131. Hy-13676
132. 17.alpha.-acetoxy-6-methyl-4,20-dione
133. Ab00490013
134. B1377
135. 17-hydroxy-6-methylpregna-4,20-dione Acetate
136. 17.alpha.-acetoxy-6-methylpregna-4,20-dione
137. C08151
138. D00952
139. D91560
140. Ab00383046-13
141. Ab00383046-14
142. Ab00383046-15
143. Ab00383046_16
144. Pregna-4,20-dione, 17-(acetyloxy)-6-methyl-
145. 595m335
146. A832354
147. Megestrol-17-acetate 1000 Microg/ml In Methanol
148. Sr-01000000258
149. Megestrol-17-acetate 100 Microg/ml In Acetonitrile
150. Pregna-4,20-dione, 17-hydroxy-6-methyl-, Acetate
151. Q-201346
152. Q6808975
153. Sr-01000000258-4
154. Brd-k19507340-001-03-1
155. Medroxyprogesterone Acetate Impurity G [who-ip]
156. Megestrol Acetate, Vetranal(tm), Analytical Standard
157. Megestrol-17-acetate 100 Microg/ml In Methanol/water
158. 17alpha-acetoxy-6-methyl-4,6-pregnadiene-3,20-dione
159. Megestrol Acetate, Analytical Standard, For Drug Analysis
160. Medroxyprogesterone Acetate Impurity G [ep Impurity]
161. Wln: L E5 B666 Ov Ku Mutj A1 E1 Fv1 Fov1 L1
162. 6-methyl-17.alpha.-hydroxy-.delta.(sup 6)-progesterone Acetate
163. Megestrol Acetate, European Pharmacopoeia (ep) Reference Standard
164. 6-methyl-3,20-dioxopregna-4,6-dien-17-yl Acetate [who-ip]
165. Megestrol Acetate, United States Pharmacopeia (usp) Reference Standard
166. Megesgtrol Acetate, Pharmaceutical Secondary Standard; Certified Reference Material
167. Megestrol Acetate For Peak Identification, European Pharmacopoeia (ep) Reference Standard
168. Megestrol Acetate For System Suitability, European Pharmacopoeia (ep) Reference Standard
Molecular Weight | 384.5 g/mol |
---|---|
Molecular Formula | C24H32O4 |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 384.23005950 g/mol |
Monoisotopic Mass | 384.23005950 g/mol |
Topological Polar Surface Area | 60.4 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 821 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 6 | |
---|---|
Drug Name | Megace |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | MEGACE (megestrol acetate, USP) Oral Suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-(acetyloxy)-6... |
Active Ingredient | Megestrol acetate |
Dosage Form | Suspension |
Route | Oral |
Strength | 40mg/ml |
Market Status | Prescription |
Company | Bristol Myers Squibb |
2 of 6 | |
---|---|
Drug Name | Megace es |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Megace ES oral suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-Hydroxy-6-methyl pregna-4,6-diene-3... |
Active Ingredient | Megestrol acetate |
Dosage Form | Suspension |
Route | Oral |
Strength | 125mg/ml |
Market Status | Prescription |
Company | Par Pharm |
3 of 6 | |
---|---|
Drug Name | Megestrol acetate |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Megestrol acetate is a synthetic, antineoplastic and progestational drug. Megestrol acetate is a white, crystalline solid chemically designated as 17(alpha)-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione. Solubility at 37C in water is 2 mcg per mL... |
Active Ingredient | Megestrol acetate |
Dosage Form | Tablet; Suspension |
Route | Oral |
Strength | 125mg/ml; 40mg/ml; 40mg; 20mg |
Market Status | Prescription |
Company | Twi Pharms; Wockhardt; Par Pharm; Roxane; Teva Pharms; Barr |
4 of 6 | |
---|---|
Drug Name | Megace |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | MEGACE (megestrol acetate, USP) Oral Suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-(acetyloxy)-6... |
Active Ingredient | Megestrol acetate |
Dosage Form | Suspension |
Route | Oral |
Strength | 40mg/ml |
Market Status | Prescription |
Company | Bristol Myers Squibb |
5 of 6 | |
---|---|
Drug Name | Megace es |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Megace ES oral suspension contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone. Megestrol acetate is a white, crystalline solid chemically designated as 17-Hydroxy-6-methyl pregna-4,6-diene-3... |
Active Ingredient | Megestrol acetate |
Dosage Form | Suspension |
Route | Oral |
Strength | 125mg/ml |
Market Status | Prescription |
Company | Par Pharm |
6 of 6 | |
---|---|
Drug Name | Megestrol acetate |
PubMed Health | Megestrol Acetate (By mouth) |
Drug Classes | Endocrine-Metabolic Agent |
Drug Label | Megestrol acetate is a synthetic, antineoplastic and progestational drug. Megestrol acetate is a white, crystalline solid chemically designated as 17(alpha)-(acetyloxy)-6-methylpregna-4,6-diene-3,20-dione. Solubility at 37C in water is 2 mcg per mL... |
Active Ingredient | Megestrol acetate |
Dosage Form | Tablet; Suspension |
Route | Oral |
Strength | 125mg/ml; 40mg/ml; 40mg; 20mg |
Market Status | Prescription |
Company | Twi Pharms; Wockhardt; Par Pharm; Roxane; Teva Pharms; Barr |
For the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). Also used for the palliative management of recurrent, inoperable, or metastatic breast cancer, endometrial cancer, and prostate cancer in Canada and some other countries.
FDA Label
Megestrol is a synthetic progestin and has the same physiologic effects as natural progesterone. These effects include induction of secretory changes in the endometrium, increase in basal body temperature, pituitary inhibition, and production of withdrawal bleeding in the presence of estrogen. Mestrogel has slight glucocorticoid activity and very slight mineralocorticoid activity. This drug has no estrogenic, androgenic, or anabolic activity. The precise mechanism of megestrol’s antianorexic and anticachetic effects is unknown. Initially developed as a contraceptive, it was first evaluated in breast cancer treatment in 1967.
Antineoplastic Agents, Hormonal
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)
Appetite Stimulants
Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS. (See all compounds classified as Appetite Stimulants.)
Absorption
Variable, but well absorbed orally.
Route of Elimination
The major route of drug elimination in humans is urine. Respiratory excretion as labeled carbon dioxide and fat storage may have accounted for at least part of the radioactivity not found in urine and feces.
Primarily hepatic. Megestrol metabolites which were identified in urine constituted 5% to 8% of the dose administered. Respiratory excretion as labeled carbon dioxide and fat storage may have accounted for at least part of the radioactivity not found in urine and feces. No active metabolites have been identified.
34 hours
The precise mechanism by which megestrol acetate produces effects in anorexia and cachexia is unknown at the present time, but its progestin antitumour activity may involve suppression of luteinizing hormone by inhibition of pituitary function. Studies also suggest that the megestrol's weight gain effect is related to its appetite-stimulant or metabolic effects rather than its glucocorticoid-like effects or the production of edema. It has also been suggested that megestrol may alter metabolic pathyways via interferences with the production or action of mediators such as cachectin, a hormone that inhibits adipocyte lipogenic enzymes.
About the Company : Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.
...
About the Company : A research-based international pharmaceutical company, Coral Drugs has more than 27 years of expertise in manufacturing a wide variety of high-quality and affordable active pharmac...
About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Symbiotec, a leading API manufacturing company based in Indore, Central India, specializes in Cortico-Steroids and Steroid-Hormone APIs. Since 1995, their focus on R&D, sustainable...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
About the Company : Hanways Chempharm Co., Limited, the former one is Hubei Hanways Pharchem CO.,Limited, set up in 2009 in Wuhan, China. We are engaged in supplying APIs, pharmaceutical intermediate...
About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...
About the Company : With the high technology and excellent services, Xianju pharma earned a top worldwide reputation for quality in pharmaceutical industry. Xianju pharma has dedicated to scientific r...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : RX
Registration Country : USA
Brand Name : MEGESTROL ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Packaging :
Approval Date : 1988-08-08
Application Number : 72422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MEGESTROL ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Packaging :
Approval Date : 1988-08-08
Application Number : 72423
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MEGESTROL ACETATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2001-07-25
Application Number : 75671
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Oral Solution
Dosage Strength : 40MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MEGACE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1993-09-10
Application Number : 20264
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MEGESTROL ACETATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML
Packaging :
Approval Date : 2003-05-05
Application Number : 75681
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name : MESTROL-160
Dosage Form : Tablet
Dosage Strength : 160mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Sweden
Brand Name : Megace
Dosage Form : TABLETT
Dosage Strength : 160 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
RLD : No
TE Code : AB
Brand Name : MEGESTROL ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Approval Date : 1988-08-08
Application Number : 72422
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : MEGESTROL ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Approval Date : 1988-08-08
Application Number : 72423
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : MEGESTROL ACETATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML
Approval Date : 2001-07-25
Application Number : 75671
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : MEGESTROL ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Approval Date : 1995-11-30
Application Number : 74621
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code :
Brand Name : MEGESTROL ACETATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 125MG/ML
Approval Date : 2017-12-01
Application Number : 204688
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : MEGESTROL ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Approval Date : 1995-09-29
Application Number : 74458
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : MEGESTROL ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 40MG
Approval Date : 1995-09-29
Application Number : 74458
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : MEGESTROL ACETATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 40MG/ML
Approval Date : 2017-06-09
Application Number : 203960
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : MEGESTROL ACETATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 125MG/ML
Approval Date : 2014-08-27
Application Number : 203139
RX/OTC/DISCN : RX
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : MEGESTROL ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Approval Date : 1987-10-02
Application Number : 70646
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Regulatory Info :
Registration Country : Italy
Brand Name : Megexia
Dosage Form : Megestrol 160Mg 30 Joined' Oral Use
Dosage Strength : 30 CPR 160 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : EU CTD Dossier Available
Registration Country : Hungary
Brand Name :
Dosage Form : Tablet
Dosage Strength : 160MG
Packaging : 30 Tabs & 100 Tabs
Approval Date :
Application Number :
Regulatory Info : EU CTD Dossier Available
Registration Country : Hungary
Regulatory Info :
Registration Country : Italy
Brand Name : Gestroltex
Dosage Form : Megestrol 160Mg 30 Joined' Oral Use
Dosage Strength : 30 CPR 160 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : MEGEXIA
Dosage Form : Tablets
Dosage Strength : 160 mg
Packaging : 30 UNITS 160 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : MEGESTIL
Dosage Form : Tablets
Dosage Strength : 160 mg
Packaging : 30 UNITS 160 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Sweden
Brand Name : Megace
Dosage Form : TABLETT
Dosage Strength : 160 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Megestil
Dosage Form : Megestrol 160Mg 30 Joined' Oral Use
Dosage Strength : 30 CPR 160 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Megefren 160Mg 30 Tablets
Dosage Form : Tablet
Dosage Strength : 60 Mg/Tablet
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Megefren 160Mg/30 Envelopes Grain On Oral Solution
Dosage Form : Oral Solution
Dosage Strength : 160 Mg/Oral Solution
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Spain
Brand Name : Borea 160Mg 30 Envelopes
Dosage Form : Oral Solution/Suspension
Dosage Strength : 160 Mg/ORAL SOLUTION/SUSPENSION
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
15
PharmaCompass offers a list of Megestrol Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Megestrol Acetate manufacturer or Megestrol Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Megestrol Acetate manufacturer or Megestrol Acetate supplier.
PharmaCompass also assists you with knowing the Megestrol Acetate API Price utilized in the formulation of products. Megestrol Acetate API Price is not always fixed or binding as the Megestrol Acetate Price is obtained through a variety of data sources. The Megestrol Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Megestat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Megestat, including repackagers and relabelers. The FDA regulates Megestat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Megestat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Megestat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Megestat supplier is an individual or a company that provides Megestat active pharmaceutical ingredient (API) or Megestat finished formulations upon request. The Megestat suppliers may include Megestat API manufacturers, exporters, distributors and traders.
click here to find a list of Megestat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Megestat DMF (Drug Master File) is a document detailing the whole manufacturing process of Megestat active pharmaceutical ingredient (API) in detail. Different forms of Megestat DMFs exist exist since differing nations have different regulations, such as Megestat USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Megestat DMF submitted to regulatory agencies in the US is known as a USDMF. Megestat USDMF includes data on Megestat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Megestat USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Megestat suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Megestat Drug Master File in Korea (Megestat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Megestat. The MFDS reviews the Megestat KDMF as part of the drug registration process and uses the information provided in the Megestat KDMF to evaluate the safety and efficacy of the drug.
After submitting a Megestat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Megestat API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Megestat suppliers with KDMF on PharmaCompass.
A Megestat CEP of the European Pharmacopoeia monograph is often referred to as a Megestat Certificate of Suitability (COS). The purpose of a Megestat CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Megestat EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Megestat to their clients by showing that a Megestat CEP has been issued for it. The manufacturer submits a Megestat CEP (COS) as part of the market authorization procedure, and it takes on the role of a Megestat CEP holder for the record. Additionally, the data presented in the Megestat CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Megestat DMF.
A Megestat CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Megestat CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Megestat suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Megestat as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Megestat API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Megestat as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Megestat and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Megestat NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Megestat suppliers with NDC on PharmaCompass.
Megestat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Megestat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Megestat GMP manufacturer or Megestat GMP API supplier for your needs.
A Megestat CoA (Certificate of Analysis) is a formal document that attests to Megestat's compliance with Megestat specifications and serves as a tool for batch-level quality control.
Megestat CoA mostly includes findings from lab analyses of a specific batch. For each Megestat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Megestat may be tested according to a variety of international standards, such as European Pharmacopoeia (Megestat EP), Megestat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Megestat USP).